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Introduction
Schistosomiasis is a chronic helminth disease of humans caused by digenean trematodes of the genus Schistosoma. Although this disease has been successfully controlled in many countries, it is still a major threat to public health as approximately 260 million people in over 78 countries are infected (World Health Organization, 2015) . Chronic infection with the Asiatic Schistosoma japonicum ranges from mild hypersensitivity reactions to granuloma formation, periportal fibrosis, portal hypertension, porto-caval shunting, and bleeding from gastrointestinal varices, which may be fatal (Gryseels et al., 2006; Burke et al., 2009) . Pathology is associated with the host CD4+ Th2 response, with IL-4 and IL-13 the dominant cytokines responsible . Chemokines and their receptors have also been shown to play an important role in the development of schistosome egg-induced granuloma formation (Chuah et al., 2014a) . The transcriptional regulation of hepatic schistosomiasis japonica in mouse models has been investigated during the acute phase of granuloma formation (Burke et al., 2010a, b; Perry et al., 2011; Chuah et al., 2013) ; however less is known regarding the more chronic phases and the events that occur in the liver during recovery after parasite clearance.
Current efforts to control schistosomiasis rely solely on the drug praziquantel (PZQ) (Xiao et al., 2009) . The pharmacological actions of PZQ on adult schistosomes are considered to be calcium-dependent (Doenhoff et al., 2008) , and the participation of host complement in vivo is also an important co-factor for parasite elimination (La Flamme et al., 2003) . PZQ, in addition to its anti-helminth effect, is reported to have anti-inflammatory properties (Ribeiro-dos-Santos et al., 2006) . PZQ administration significantly reduces granuloma area, the number of inflammatory cells within the granulomas (Yang et al., 1984; Huang et al., 2011) , and the levels of inflammatory cytokines in the blood (Silveira-Lemos et al., 2013) . PZQ treatment successfully decelerated hepatic fibrosis in patients suffering from schistosomiasis mansoni (Zwingenberger et al., 1990) , and can also reverse pulmonary hypertension and vascular remodelling in a murine model of Schistosoma mansoni infection (Crosby et al., 2011) . The transcriptional response of the parasite to PZQ has advanced the understanding of its mode of action (Gobert, 2010) . While some insights have been made in regards to the anti-parasite response of PZQ for both S. japonicum (You et al., 2013) and S. mansoni (Aragon et al., 2009; Hines-Kay et al., 2012; Kasinathan et al., 2014) , less is understood regarding the impact of the drug on host tissues, particularly in the main organ of pathology, the liver.
Schistosomiasis is a disease caused predominantly by the host immune response to schistosome eggs (ova) and the granulomatous reaction they evoke (Pearce and MacDonald, 2002) .
Granulomas are formed to destroy eggs and sequester or neutralize otherwise pathogenic egg antigens but this process also leads to host tissue fibrosis (Wilson et al., 2007) . Transforming growth factor beta (TGF-β) is involved in the process of liver regeneration after partial hepatectomy (Braun et al., 1988) , and it plays a role in hepatocyte proliferation in the regenerating liver (Thenappan et al., 2010) . In schistosomiasis, the regression of hepatic granuloma and the downmodulation of the Th2 response are thought to be mediated by IL-10 secreting T regulatory cells (Hesse et al., 2004) , and the role of IL-13Rɲ2 in the resolution of fibrosis has been reported (Chiaramonte et al., 2003) . However, the specific mechanisms leading to liver recovery are still not clear. In this study, we describe the application of a mouse model of S. japonicum treated with PZQ to allow liver recovery, and the characterisation of these events using histology and by whole genome microarray analysis. These results provide novel insights on hepatic cellular events during recovery after hepatic schistosomiasis.
Materials and methods

Ethics statement
All animal studies were conducted with the approval of the Animal Ethics Committee of QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Parasites and mouse infections
A total of 42, 4 -6 week old female C57BL/6 mice (n = 6 per group) were percutaneously infected with 14 ± 1 S. japonicum cercariae (Chinese mainland, Anhui population). An additional 14 C57BL/6 mice were used as uninfected controls.
Drug administration
The mice were divided into groups (Fig. 1) designated as: PZQ-treated infected mice (PI; n = 18, six mice per time point); untreated infected mice (NI; n = 24, six mice per time point); PZQtreated uninfected mice (PU; n = 12, four mice per time point); and untreated uninfected mice (NU; n = 2). A group of six infected mice (from group NI) was euthanised at 6 weeks p.i. before the commencement of PZQ treatment, to provide baseline data. Mice receiving PZQ treatment (Groups PI and PU) were orally administered 150, 200, 250, 300 and 350 mg/kg PZQ prepared in 2.5% (v/v) Cremophor EL (Sigma, USA) for five consecutive days at 7 weeks p.i. Groups NI, PI and PU were euthanised 3, 6 and 7 weeks post PZQ treatment (10, 13 or 14 weeks post cercarial challenge, respectively) and the absence of worms was confirmed at sacrifice (see Section 2.4).
Parasitological, pathological and histological assessment
Adult worms were obtained and counted following perfusion from the intestinal mesenteric veins, and mouse livers and spleens were collected for assessment of hepatosplenomegaly. The small lobe of the liver was used for histology (see below), then the remaining tissue was divided for RNA isolation and egg counts. Hepatic egg burden was calculated as the number of eggs per gram of liver (EPG) as previously described (Burke et al., 2010a) . Faeces were collected 1 week before PZQ administration to microscopically confirm the presence of parasite eggs and again 1 week after PZQ treatment to ensure that treatment was effective, as described (You et al., 2012) .
The small lobe of liver from each mouse was formalin-fixed 10% (v/v) and paraffinembedded, and liver sections were then stained with H&E to assess granuloma density, and PicroSirius Red for collagen to measure hepatic fibrosis (Perry et al., 2011) . Leder and Giemsa staining measured neutrophil and eosinophil infiltration, while quantitation was carried out by determining the average number of positive-stained cells over 20 fields at high magnification as previously described (Burke et al., 2010a) . Macrophage recruitment was evaluated by F4/80 immunostaining and quantitated using Aperio's Spectrum Plus software Positive Pixel Count Algorithm (Burke et al., 2010b) . slides were digitised using the Aperio Slide Scanner (Aperio Technologies, USA).
Total RNA isolation
Total RNAs from all liver samples were isolated using Trizol and a RNeasy Mini Kit (Qiagen, Germany) following the manufacturer's instructions. Total RNA quantity was measured using a Nanodrop-1000 spectrophotometer (Nanodrop Technologies, USA) and RNA quality was assessed using an Agilent Bioanalyzer (Agilent Technologies, USA).
Microarray analysis
Microarray analyses were performed using Illumina Mouse Ref-8 Version 2 whole genome expression arrays as previously reported (Chuah et al., 2013) . Details of cRNA synthesis and Whole Genome Microarray Hybridisation, Feature Extraction and data analysis, and Ingenuity Pathway Analysis (IPA), are outlined in Supplementary Data S1. All gene expression data have been submitted to Gene Expression Omnibus (National Center for Biotechnology Information (NCBI), USA) and are publicly available (Series Accession Number, GSE59276).
Quantitative real-time PCR (qRT-PCR)
cDNA was synthesized using a Quantitect Reverse Transcription kit (Qiagen) and cDNA concentration quantified using a Nanodrop-1000 spectrophotometer (Nanodrop Technologies).
qRT-PCR was performed using SYBR Green master mix (Applied Biosystems, USA) on a Corbett Rotor Gene 6000 (Corbett Life Sciences, Australia). Hypoxanthine phosphoribosyltranferase (HPRT) was used as a housekeeping gene as described (Dheda et al., 2004) . Quantitative real-time PCR (qRT-PCR) was used to validate a subset of microarray data representing those transcripts that were significantly expressed (up-or down-regulated) by microarray analysis. Primers for qRT-PCR were designed using Primer 3 software (http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and are listed in Supplementary Table S1 .
Immunohistochemistry
The Ki67 (a marker for cellular proliferation) and tissue inhibitor of metalloproteinase-1 (TIMP1) proteins were immunolocalised using paraffin-embedded section described in Section 2.4.
Full details of the processing procedures are presented in Supplementary Data S1. Two analysis strategies were used for quantitation of staining as described below.
Semi-quantitative analysis
Hepatocytes and biliary epithelium over five randomly chosen high power fields in each section were assessed for Ki67 staining. The entire section was also screened for TIMP1 staining and areas containing positively staining cells were characterised. This semi-quantitative survey was performed by a veterinary pathologist (co-author Helen C. Owen), who was blinded to the experimental groupings.
Quantitative analysis
Aperio images were analysed using the Aperio Imagescope v11.1.2.760 software. Positive Pixel Count V9 algorithm was optimised to count TIMP1 stained cells. Nuclear algorithm V9 was used to quantitate cells stained with Ki67. The percentage of positive cells was calculated by comparing the strong positive cells to the total number of positive and negative cells. Data were analysed using GraphPad Prism Version 6.0 software, with significance between treatment groups and weeks determined using One-way ANOVA (P ≤0.05).
Statistical analyses
Statistical analyses of histological and pathological data were performed using GraphPad Prism Version 6.0 (GraphPad Software, USA). Changes in parasitological and histological data of the untreated group were assessed by one-way ANOVA, whereas two-way ANOVA (P ≤0.05) was used to examine changes in the PZQ-treated infected group (Group PI) compared with the untreated infected group (Group NI) and the PZQ-treated uninfected group (Group PU). The correlation between microarray data and qRT-PCR was measured using Spearman's correlation in GraphPad Prism Version 6.0 as previously reported (Morey et al., 2006) .
Results
General histopathological features
Uninfected mice (Groups PU and NU) showed normal hepatic lobular architecture ( Fig. 2A) .
Schistosome eggs observed in the liver at 6 weeks p.i. were surrounded by a dense population of neutrophils and infiltrative macrophages within a band of proliferating fibrovascular tissue (Fig.   2B ). At 10 weeks p.i., eggs were surrounded by a dense population of macrophages interspersed with a few aggregates of neutrophils with a further ring of lymphocytes at the periphery (Fig. 2C ).
At 13 and 14 weeks p.i., most eggs were calcified and surrounded by varying proportions of lymphocytes, fibrosis in a collagenous stroma and macrophages including multinucleated giant cells ( Fig. 2D -E) . The granulomas of PZQ-treated, infected mice (Group PI) predominantly contained remnants of egg shells, presented less cellular infiltrates and were surrounded by concentric bands of fibrous tissue ( Fig. 2F -H) .
Parasitological and histological analyses
Schistosoma japonicum adult worm pairs were present in each infected mouse (Fig. 3A) .
Positive infections were confirmed prior to PZQ treatment by copro-microscopic examination. PZQ administration successfully eliminated all adult parasites (P ≤0.001), as determined by faecal egg examination and eventual worm counts at the time of host sacrifice and perfusion. Livers of untreated, infected mice (Group NI) attained the highest weight at 10 week p.i., and decreased significantly at week 14 p.i. (P ≤0.05) (Fig. 3B ). There were no significant liver weight differences in untreated, infected mice (Group NI) compared with PZQ-treated, infected mice (Group PI) at any time points. Spleen weights of untreated, infected mice (Group NI) increased significantly from 6 weeks p.i. onwards (P ≤0.001). There was a significant reduction in the spleen weight of PZQtreated, infected mice (Group PI) 3, 6, and 7 weeks after PZQ treatment compared with untreated, infected mice (Group NI) (P ≤0.0001). The spleen weight of PZQ-treated, infected mice (Group PI) and PZQ-treated, uninfected controls (Group PU) did not differ significantly after 6 and 7 weeks post PZQ treatment. The data of both liver and spleen weights of untreated, uninfected controls (Group NU) at 6 weeks are also included (Fig. 3 ). Both the liver and spleen weights of untreated, infected mice (Group NI) at 6 weeks p.i. increased significantly compared with the untreated, uninfected controls (Group NU) at same time point (P ≤0.05).
Hepatic egg burden increased in untreated, infected mice (Group NI) from 6 weeks p.i. onwards ( Fig. 3D ) (P ≤0.01), and increased significantly compared with the untreated, uninfected controls (Group NU) (P ≤0.01). There was no significant difference in the number of eggs in the liver of PZQ-treated, infected (Group PI) or untreated, infected mice (Group NI) at any time point.
Higher numbers of egg clusters were present in the infected liver of untreated mice (Group NI) at 10 weeks p.i. compared with 6 week p.i. (P ≤0.001), and these decreased significantly thereafter at 13 weeks p.i. (P ≤0.05) (Fig. 3C ). Egg clustering also increased significantly in the untreated, infected mice (Group NI) at 6 weeks p.i. compared with the untreated, uninfected controls (Group NU) (P ≤0.01). The distribution of egg clusters in PZQ-treated, infected mice (Group PI) was reduced after 7 weeks of PZQ treatment compared with the untreated, infected group (Group NI) (P ≤0.01), and no significant difference was observed in egg clustering of PZQ-treated, infected (Group PI) or PZQ-treated, uninfected mice (Group PU) after 6 and 7 weeks of PZQ treatment.
Granuloma density (Fig. 4A -C) , the degree of fibrosis (Fig. 4D -F were assessed and presented. Granuloma density of untreated, infected mice (Group NI) increased significantly at 6 weeks p.i. compared with the untreated, uninfected mice (Group NU) (P ≤0.001) (Fig. 5A ). Granuloma density was significantly greater in untreated, infected mice (Group NI) compared with PZQ-treated, infected mice (Group PI) (P ≤0.05). The area of granulomas in the PZQ-treated, infected mice (Group PI) did not differ significantly from the PZQ-treated, uninfected mice (Group PU). Fibrosis, as indicated by collagen staining, was first observed in mature granulomas at 6 weeks p.i. and was also prominent around the portal vein of the liver. The extent of fibrosis in the infected livers of untreated mice (Group NI) was higher at 10 -14 weeks p.i. compared with 6 weeks p.i. (P ≤0.001) (Fig. 5B ). Fibrosis of this group was also significantly higher at 6 weeks p.i. compared with the untreated, uninfected mice at a similar time-point (Group NU) (P ≤0.01). Fibrosis decreased from 10 -14 weeks p.i. but this change was not significant. The fibrotic response in PZQ-treated, infected mice (Group PI) was reduced significantly compared with that of untreated, infected mice (Group NI) after 3 weeks of PZQ treatment (P ≤0.01). The degree of fibrosis between PZQ-treated, infected (Group PI) and PZQ-treated, uninfected mice (Group PU) did not differ significantly after 6 and 7 weeks of PZQ treatment.
F4/80 staining for macrophages indicated infiltration in the infected livers of untreated mice (Group NI) peaked at week 10 p.i. (Fig. 5C ). Macrophage infiltration into untreated, infected livers (Group NI) 6 weeks p.i. was significantly greater compared with untreated, uninfected mice (Group NU) (P ≤0.05) at the exact time point. The infiltration of macrophages to the PZQ-treated, infected livers (Group PI) decreased significantly compared to the untreated, uninfected livers (Group NU) (P ≤0.05). There was no significant difference in the numbers of macrophages in the PZQ-treated, infected (Group PI) or PZQ-treated, uninfected livers (Group PU) at any time point.
The extent of neutrophil infiltration in the infected liver of untreated mice (Group NI) peaked at 10 weeks p.i. and decreased thereafter, (P ≤0.01) (Fig. 5D ). Neutrophil infiltration of the untreated, infected mice (Group NI) at 6 weeks p.i. was significantly higher compared with the untreated, uninfected mice (Group NU) (P ≤0.001). The recruitment of neutrophils to the PZQtreated, infected liver (Group PI) decreased significantly after PZQ treatment,compared with the means of untreated, infected livers (Group NI) (P ≤0.0001). There was no significant difference in the numbers of neutrophils in the PZQ-treated, infected (Group PI) or PZQ-treated, uninfected livers (Group PU) after 6 and 7 weeks of PZQ treatment.
Eosinophil infiltration peaked at 10 weeks p.i. and did not change in numbers thereafter (P ≤0.05) (Fig. 5E ). The infiltration of eosinophils to the infected livers of untreated mice (Group NI) after 6 weeks p.i. was significantly higher than the untreated, uninfected mice (Group NU) (P ≤0.001). Eosinophil numbers in the PZQ-treated, infected liver (Group PI) were significantly lower than in untreated, infected livers (Group NI) after 7 weeks of PZQ treatment (P ≤0.05). There was no difference in eosinophil numbers between PZQ-treated, infected (Group PI) and PZQ-treated, uninfected mice (Group PU) after 6 and 7 weeks of PZQ treatment.
Microarray analysis: data normalisation and filtration
During the S. japonicum infection (6 to 14 weeks p.i.) normalised gene expression data for each of the 25,697 genes on the Illumina microarray were filtered for significant signal and normalised to untreated, uninfected controls (Group NU) reducing the data set to 11,872 genes (Supplementary Table S2 ). Of these, 1,830 genes (Supplementary Table S3 ) were shown to be differentially expressed with a ± two-fold change in at least one individual sample at each time point (one -way ANOVA, P ≤0.05). Transcriptional changes in the PZQ-treated, infected liver (Group PI) after 3, 6, and 7 weeks of PZQ treatment were examined by normalising the 25,697 genes on the array platform to each of the untreated, infected samples (Group NI) at the same timepoints. This reduced the data set to 516, 402 and 1,099 differentially expressed genes (Supplementary Table S4 ) with a ± two-fold change after 3, 6 and 7 weeks of PZQ treatment, respectively. For the assessment of gene changes due to PZQ alone, data for PZQ-treated, uninfected mice (Group PU) were filtered and normalised to the uninfected controls without PZQ treatment (Group NU). This reduced the data list from 25,697 to 10,758 genes, of which seven genes were shown to be significantly up-regulated with a ± 1.5-fold change (Supplementary Table   S5 ).
Genes differentially up-regulated during progression of S. japonicum infection (Group NI)
IPA revealed that genes significantly up-regulated more than two-fold (P ≤0.05) during the chronic progression of S. japonicum infection compared with untreated, uninfected livers (Group NU), were primarily related to IL-8 signaling (P value 4.79E-07, see Table 1 and Supplementary Data S2) and the dendritic cell (DCs) maturation pathway (P value 1.91E-07, see Table 2 and Supplementary Data S2). Expression of IL-8 associated genes included Myeloperoxidase (MPO), Matrix Metalloproteinase 9 (MMP9), Myosin Light Chain Regulatory B (MYLC2B), and Arrestin Beta 2 (ARRB2) with higher expression at 10 or 14 weeks p.i., paralleling increased granuloma density and collagen deposition at these time points.
Genes associated with DC maturation pathways (Table 2) showed peaked expression at 6 weeks p.i. and included genes such as Fc receptors (FCGR3A, FCER1G, FCGR2A, FCER1G) Other canonical pathways indentified by IPA in the liver of acute to chronic mice (Group NI, from 6 to 14 weeks p.i.) included LPS/IL-1 Mediated Inhibition of RXR Function (P value 3.16E-15), Acute Phase Response Signaling (P value 5.01E-14), Xenobiotic Metabolism Signaling (P value 2.00E-12), Aryl Hydrocarbon Receptor Signaling (P value 2.00E-11), FXR/RXR Activation (P value 2.51E-11), Fatty Acid oxidation I (P value 7.76E-10), Oxidative Phosphorylation (P value 1.07E-09), Serotonin Degradation (P value 2.63E-09) and Leukocyte Extravasation Signaling (P value 3.02E-09) (see Supplementary Data S2).
Gene expression related to hepatocyte growth was down-regulated during acute and chronic disease (Group NI, from 6 to 14 weeks p.i.) relative to untreated, uninfected controls (Group NU) included HGFAC: hepatocyte growth factor activator (-2.66, -2.6, -1.79, -3.24 fold; weeks 6, 10, 13, 14) and PCBD2: dimerization cofactor of hepatocyte nuclear factor 1 alpha 2 (-1.79, -1.88, -1.66, -2.09 fold; weeks 6, 10, 13, 14) (see entary Table S3 ). TIMP1 (17.48, 10.89, 6.41, 10 .24 fold; weeks 6, 10, 13, 14) a gene associate with tissue remodelling was elevated during the acute and chronic disease (Group NI, from 6 to 14 weeks p.i.) relative to untreated, uninfected controls (Group NU) peaking at 17.5 fold at 6 weeks p.i. (see Supplementary Table S3) .
Genes differentially up-regulated in PZQ-treated, S. japonicum-infected mice (Group PI) compared with untreated, S. japonicum-infected mice model (Group NI)
Peroxisome proliferator activated receptor alpha (PPAR-α) was identified by IPA (P value 3.66E-63, see Supplementary Data S3) as an "activated" upstream regulator of the recovery phase of the liver after 3, 6 and 7 weeks of PZQ treatment. PPAR-α is a ligand-activated transcription factor that plays critical role in the regulation of hepatic fatty acid metabolism (Crabb et al., 2004) .
The identification of this upstream regulator enables the understanding of the series of transcriptional cascades and biological activities occurring in the recovering liver treated with PZQ.
Transcriptomic analyses showed that the top highly up-regulated genes 3, 6 and 7 weeks post PZQ treatment were mainly associated with fatty acid and xenobiotic metabolism with peak expression at 7 weeks post-treatment (Table 3) Expression of most genes peaked (within the time frame examined) 7 weeks post treatment, indicating that this time point is critical in the recovery process. IPA identified enrichment of aryl hydrocarbon receptor (AhR) signaling (P value 3.3E-10, see Supplementary Data S3) after 7 weeks of PZQ treatment compared with the untreated, infected group at the same time point (Table 4) . This receptor is involved in the regulation of enzymes responsible for xenobiotic metabolism (Ramadoss et al., 2005) .
Other canonical pathways identified by IPA (see Supplementary Data S3) included LPS/IL-1 Mediated Inhibition of RXR Function (P value 1.00E-18), Xenobiotic Metabolism Signaling (P value 2.00E-12), Nicotine Degradation II (P value 3.98E-12), FXR/RXR Activation (P value 5.01E-12), LXR/RXR Activation (P value 1.00E-11), Serotonin Degradation (P value 1.58E-11), Superpathway of Melatonin Degradation (P value 3.16E-11), Glutathione-mediated Detoxification (P value 1.70E-10), Nicotine Degradation III (P value2.09E-10) and Acute Phase Response Signaling (P value 2.95E-10).
In contrast to acute/chronic schistosomiasis (Group NI, 6 to 14 weeks p.i.), during disease recovery genes related to hepatocyte growth were up-regulated included HGFAC (2.28 fold; 7 weeks post PZQ treatment) and PCBD2 (2.18 fold; 7 weeks post PZQ treatment) (see Supplementary Table S4) . TIMP1 (-4.07, -4.25, -7.63 fold; 3, 6, 7 weeks post PZQ treatment), a gene associated with tissue remodelling was reduced during tissue recovery (relative to infected time course matches) with -7.7 fold evident at 7 weeks post PZQ administration (see Supplementary   Table S4 ).
Genes differentially up-regulated in PZQ-treated, uninfected mice (Group PU) compared with untreated, uninfected mice (Group NU)
No genes were differentially up-regulated by more than two-fold in the PZQ-treated, uninfected mice (Group PU) compared with the untreated, uninfected mice (Group NU). The following genes were down-regulated greater than two-fold at 3 weeks post-treatment but all returned above that cut off 6 and 7 weeks post treatment: Bach1 (BTB and CNC homology 1: -2.02, 1.07, 1.07 fold; 3, 6, 7 weeks post PZQ treatment), Ddx6 (DEAD box polypeptide 6: -2.47, 1.01, -1.02 fold; 3, 6, 7 weeks post PZQ treatment) and Hpn (hepsin : -2.95, -1.87, -1.82 fold; 3, 6, 7 weeks post PZQ treatment). This finding indicated that PZQ did not exert any significant transcriptional effects on healthy controls beyond 3 weeks post-drug administration.
qRT-PCR validation
The expression patterns of a subset of genes (S100A9, MPO, CYP2B9, CYP2A5, CYP8B1, CYP4A14, FMO3 and INMT) selected from the microarray analysis was validated by qRT-PCR ( Supplementary Fig. S1 ). There was a significant correlation between the expression levels obtained by qRT-PCR and microarray data (Pearson's correlation, r = 0.77; P <0.0001).
Immunohistochemistry
Wound healing and regeneration of the liver in response to PZQ treatment was investigated by assessing the expression of TIMP-1 (matrix remodelling) and Ki67 (liver cell proliferation) by immunohistochemistry, using computer analysis quantitation and a semi-quantitative and qualitative survey by a blinded veterinary pathologist.
Semi-quantitative survey
Ki67 was predominantly expressed by hepatocytes (Fig. 6A -D) . In the PZQ-treated, infected livers (Group PI), small numbers of lymphocytes in the granulomas and less commonly lymphocytes in the remaining parenchyma were also positive. Cells demonstrated mild to moderate staining intensity. The average numbers of cells staining per high power field were elevated in the untreated, infected samples at 6 weeks p.i. (Fig. 6B ) and were also high in the untreated, infected livers at 10 to 14 weeks p.i. (Fig. 6C) . Livers from PZQ-treated, infected animals had lower numbers of cells staining per high power field than the PZQ-treated, uninfected controls (Fig. 6D) . TIMP1 was predominantly expressed by mononuclear cells (lymphocytes, macrophages and plasma cells) at the periphery of the granulomas. Bile ductule epithelial cells also stained positively with TIMP 1 in untreated, infected livers at 10 to 14 weeks p.i. (Fig. 6G) . In the untreated, infected livers of 6 weeks p.i. (Fig. 6F) , the granulomas were sometimes intermittently rimmed by a band of mononuclear cells several cells thick. Up to 50% of these cells were positive. The highest number of positively staining cells was noted in the untreated, infected livers of 10 to 14 weeks p.i. (Fig.   6G ). Granulomas were often intermittently to completely rimmed by a band of mononuclear cells 15-30 cells thick, with up to 70% of these cells being positive. Distinct cellular staining was also noted in elongated myofibroblast cells located predominantly along the inner region of the TIMP1 positive band. In the PZQ-treated, infected livers (Fig. 6H ), granulomas were sometimes intermittently rimmed by a thin band of mononuclear cells several cells thick, with positively staining cells scattered throughout this area.
Quantitative analysis
As shown in Fig. 7 the immunohistochemical expression of Ki67 and TIMP1 was quantitated in untreated, infected livers (Group NI), PZQ-treated, infected livers (Group PI) and PZQ-treated, uninfected livers (Group PU). Ki67 a marker for cellular proliferation was undetectable (<0.5%) in PZQ-treated, uninfected liver sections, but was elevated to 11.1% positive cells in the untreated, infected livers of 6 weeks p.i., and continued to rise during 13 and 14 weeks p.i. reaching 34.5%. After elimination of the infection the levels of Ki67 dropped to low but still detectible levels (1.8 -3.5%). The level of TIMP1 labelling was low in PZQ-treated, uninfected tissues up to 0.5%, rising to 1.2% in the untreated, infected livers of 6 weeks p.i., but increasing substantially to 3.3% during 13 and 14 weeks p.i. In the PZQ-treated, infected livers, TIMP1 was more prominent early at week 10 at 2% but dropped to 0.6 -0.9% at weeks 13 and 14, respectively.
Discussion
While previous investigations have focused mainly on the parasitological and histopathological changes of the liver after the elimination of a schistosome infection (el-Badrawy et al., 1988; Huang et al., 2011) , the differential gene expression and pathways involved in the hepatic recovery process have not been reported. In this paper, we employed whole genome transcriptomic analyses to present a comprehensive overview of the hepatic gene signalling pathways and the associated mechanisms occurring during the progression of a murine S. japonicum infection, and the subsequent recovery events in the liver following successful PZQ treatment. The gene expression changes that we present represent two potential changes in the cellular and transcriptional profile of the whole organ. While both the transcriptional activity of individual cell types may be altered, also the relative abundance of cellular populations may be altered as demonstrated by the quantitative immunohistochemistry performed.
Progression of a chronic S. japonicum infection was significantly associated with the upregulation of genes related to IL-8 signalling. IL-8, also known as CXCL8, is a potent neutrophil chemoattractant . It has been reported previously that IL-8 responses are induced in Schistosoma haematobium-infected children (van der Kleij et al., 2004) , and the level of IL-8 was shown to be significantly higher in S. mansoni-infected individuals compared with those receiving PZQ treatment (Erikstrup et al., 2008) . Similarly, infections with S. japonicum elicited an increase in IL-8 levels in human skin (He et al., 2002) . In addition, the transcriptional level of IL-8 has been reported as being up-regulated in human neutrophils stimulated by S. japonicum eggs (Chuah et al., 2014b) . Although the gene encoding IL-8 is not present in the mouse genome, possibly due to an evolutionary duplication event (Modi and Yoshimura, 1999) , it was suggested that the murine chemokines CXCL1, CXCL2 and CXCL5 may act as the functional homologues of IL-8 (Rovai et al., 1998; Singer and Sansonetti, 2004; Hol et al., 2010) . The up-regulation of CXCL1 during the chronic progression of S. japonicum infection reported here appears to play a similar role, and may reflect the involvement of the IL-8 signalling pathway in the pathogenesis of S. japonicum infection. A recent ex vivo study of hepatic schistosomiasis, using synchronised S. japonicum soluble egg antigen exposure over 48 h, reported the transcriptional and protein upregulation of CXCL1, CXCL2 and IRAK3, supporting the importance of IL-8 related responses to S. japonicum egg antigen (Gobert et al., 2015) . The strong neutrophilic response seen in the livers of infected hosts is also reflected in the lungs of animal models of migrating schistosomula both from synchronised intravenous injections (von Lichtenberg et al., 1977) , and nature infections , indicating that proteins released by other stages have a distinct immunological response to the host.
Genes related to the DC maturation pathway were significantly up-regulated at 6 weeks p.i., and progressively down-regulated after this time-point. DCs are important messengers between the innate and adaptive immune system, playing a critical role in terms of antigen presentation, and are known to be involved in directing the polarization of the Th cellular response in schistosomiasis.
The soluble egg antigens of S. mansoni have been shown to direct DCs to promote the differentiation of naïve Th cell towards a Th2 phenotype (van Liempt et al., 2007; Everts et al., 2009; Steinfelder et al., 2009) . Lacto-N-fucopentose III (LNFPIII), a molecule present on schistosome egg glycoproteins, was also reported to drive DC maturation via a Toll-like receptor 4 (TLR4)-dependent pathway (Thomas et al., 2003) . Here, we suggest that DC maturation is part of the process occurring during the early stage of schistosomiasis japonica. Again in the ex vivo model of hepatic schistosomiasis japonica mentioned earlier, IL-1β and TLR-2 up-regulation was a feature of the first 48 h after exposure to egg antigen (Gobert et al., 2015) , which supports the findings in the current study .
Analysis of the recovering liver revealed PPAR-α as the upstream regulator of observed transcriptional changes. PPAR-α, the first identified PPAR receptor (Issemann and Green, 1990) , has an elevated transcriptional expression in tissues with high metabolic rates (Burri et al., 2010) .
The receptor PPAR-α is a ligand-activated transcription factor crucial for regulation of hepatic fatty acid metabolism and homeostasis (Desvergne et al., 2004) ; and in rodents PPAR-α gene expression is highest in the liver, followed by heart and kidney (Braissant et al., 1996) . PPAR-α-null mice suffering from a severe impairment in hepatic fatty acid oxidation, resulted in elevated levels of fatty acids and a fatty liver phenotype (Kersten et al., 1999) . Activation of PPAR-α also leads to the up-regulation of genes involved in fatty acid transport, binding and activation (Rakhshandehroo et al., 2010) . PPAR-α activation and the increased transcription of genes related to fatty acid metabolism observed in our study may thus reflect the downstream mechanism and pathway occurring in the liver undergoing recovery after schistosomiasis. Furthermore, PPAR-α is also involved in wound healing and repair, with liver regeneration in PPAR-α-null mice found to be delayed and impaired following partial hepatectomy (Anderson et al., 2002) . Using murine models PPAR-α was shown to regulate hepatic neutrophil infiltration in ischemic liver injury (Okaya and Lentsch, 2004) , while PPAR-α activation also reduced portal hypertension and liver fibrosis in carbon tetrachloride (CCl 4 )-induced cirrhotic models (Rodriguez-Vilarrupla et al., 2012) . No role for PPAR-α has been reported for hepatic schistosomiasis, and the observations we make in reference to treated and untreated infected mice are at this stage unclear but worthy of future investigations. While it is known that PPAR-α plays a critical role in regulation of hepatic fatty acid metabolism, it is unclear how this is related to Schistosoma infection or the effects of PZQ. It is likely that some other, as yet unknown, aspect of PPAR-α function may be key.
While decreased proliferation of hepatocytes was indicated by reduced gene expression of PCBD2 and HGFAC during disease progression, and the classical regulator hepatic nuclear factor 4, alpha (Hnf4a) (Walesky et al., 2013) was unchanged (<2 fold) during disease recovery, the opposite pattern was noted for PCBD2 and HGFAC. This was investigated further by the use of Ki67 staining, a classic nuclear marker for cellular proliferation (Bonzo et al., 2012) , where elevated proliferation was noted during acute and chronic disease, and reduced but still higher than uninfected controls, following PZQ treatment and subsequent tissue remodelling. These data show that the proliferation of liver cells is heightened during hepatic schistosomiasis and granuloma formation. Furthermore, while reduced during the liver recovery phase, even 3 weeks after recovery proliferation was still present above basal levels. The examination of earlier time points after parasite clearance may demonstrate a greater role for cellular proliferation in the recovering liver.
The role of TIMP1 was explored both from analysis of transcriptional data and also immunohistochemistry. TIMP1 has a clear role in inhibiting various metalloproteinases (MMPs) (Giannandrea and Parks, 2014) that normally act to degrade extracellular matrix. TIMP-1 protein expression was low in normal liver but during the acute and chronic phases of hepatic schistosomiasis it was dramatically increased before being reduced in the recovering liver following PZQ treatment. These results suggest that with TIMP-1 protein expression significantly increased at the periphery of the granuloma, matrix resorption would be inhibited by TIMP-1 binding to MMPs and suppressing their activity that would normally degrade fibrillar collagens, thus facilitating collagen deposition. One possible mechanism associated with PZQ treatment follows, the level of TIMP-1 is reduced both through down regulation of gene expression and reduction of the cellular population, resulting in increased MMP activity, thus degrading the fibrosis surrounding the granuloma, permitting wound healing and liver mass restitution. Past studies have underplayed the role of TIMP1 and MMPs in hepatic granuloma formation using S. mansoni as a model (Vaillant et al., 2001) . In previous studies, while increases in TIMP1, TIMP2 and MMP9 gene expression were evident during disease progression, the use of TIMP1 and TIMP2 knockout mice failed to demonstrate a functional correlation to disease severity in schistosomiasis mansoni (Vaillant et al., 2001 ).
As the main organ involved in drug and toxin removal, the liver plays an important role in controlling the accumulation of a wide range of toxic substances by converting them into inactive metabolites suitable for elimination (Lerapetritou et al., 2009) . Here, we show that xenobiotic metabolism genes of the cytochrome P450 family were markedly up-regulated in the regenerating schistosome-infected liver following parasite elimination. These observations are thought to be independent of the effect of PZQ administration, as PZQ-treated control mice did not show any modulation in the transcriptional expression of genes associated with xenobiotic metabolism at the time points we examined. Xenobiotics such as drugs and chemicals are mostly highly lipophilic compounds that are difficult to excrete through the kidneys, and are able to cause injury to the liver and other tissues. As the major site of xenobiotic metabolism, the liver produces hepatic enzymes such as cytochrome P450 to remove these damaging compounds (Sturgill and Lambert, 1997) . The role of cytochrome P450 in active and recovering hepatic schistosomiasis is not clear at this stage and will require future work to clearly elucidate its function. The expression of cytochrome P450 enzymes are in turn regulated by AhR, also known as the xenobiotic receptor, a ligand-dependent transcription factor (Beischlag et al., 2008) . It was reported previously that AhR-deficient mice showed a decrease in the size of hepatocytes and the organ as a whole, indicating that AhR plays an important role in the development of normal liver function (Fernandez-Salguero et al., 1995; Lahvis et al., 2000) . Consistent with the increased expression of xenobiotic genes, the AhR signalling pathway was also shown to be up-regulated in our model of recovering liver, demonstrating the significance of xenobiotic detoxification processes as a part of the regulation of hepatic function.
In summary, we present the most comprehensive known pathological and transcriptional profile of the chronic and recovery phases of schistosome-infected livers in the murine model. We show that granulomatous pathology and the extent of fibrosis were greatly reduced following elimination of the adult parasite and the cessation of egg laying, and these events were accompanied by a decrease in the numbers of immune cell infiltrates to the liver. Our findings indicate, to our knowledge for the first time, the involvement of PPAR-α activation and the AhR signalling pathway in the regenerative process of liver recovery. The significant up-regulation of metabolic genes in the recovering liver as well marks the successful regression and remodelling of the liver. were administered an increasing dosage of PZQ (Group PI) over five consecutive days at 7 weeks p.i. Uninfected mice were also treated with PZQ (Group PU) to assess the hepatotoxic effect of the drug. Untreated infected (Group NI), PZQ-treated infected (Group PI) and the PZQ-treated uninfected mice (Group PU) were euthanised at 10, 13, 14 weeks p.i. The NU group (not included into this figure) represents the uninfected mice that did not receive PZQ treatment. showing varying proportions of lymphocytes, fibrosis in a collagenous stroma and macrophages. A variable population of neutrophils is scattered through this area, and most of the eggs present are calcified. Granulomas in PZQ-treated at week 7 post cercarial challenge mice (Group PI) after (F) 3, (G) 6 and (H) 7 weeks of PZQ treatment have started to decrease in size and show reduced cellular infiltration, with only a scattering of lymphocytes and plasma cells, and a few macrophages present.
Figure Legends
All liver sections shown are formalin-fixed, paraffin-embedded and stained with H&E. Scale bar = 100 µm. (n = 6) * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001. and chronic (10, 13 and 14 weeks p.i.) phases. Animals were infected with S. japonicum, treated with PZQ at week 7 p.i. to clear the infection, and the tissue allowed to recover; tissues were sampled at weeks 10, 13 and 14 p.i.. Significant differences between treatment groups (PI, PZQtreated infected mice; PU, PZQ-treated uninfected mice; NI, untreated infected mice) and weeks are indicated by: * P ≤ 0.05, ** P ≤ 0.01, **** P ≤ 0.0001. japonicum-infected; PU, PZQ-treated, uninfected. Significant differences between treatment groups and weeks are indicated by: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001.
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